FNArena Windows
Introduction to FNArena Windows
FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.
| ASX CODE | LAST PRICE | % MOVE | 52WK HIGH | 52WK LOW | P/E | CONSENSUS TARGET | UPSIDE/DOWNSIDE |
|---|---|---|---|---|---|---|---|
| 4DX | $1.58 |
|
$2.55 | $0.23 |
$2.075 |
|
|
| AT1 | $0.03 | 0.00% | $0.03 | $0.01 |
|
||
| AYA | $3.03 |
|
$4.02 | $0.42 |
|
||
| BB1 | $0.81 |
|
$0.83 | $0.24 |
|
||
| BRN | $0.17 | 0.00% | $0.45 | $0.17 |
|
||
| CAT | $5.04 |
|
$7.72 | $2.98 | -41.1 |
$6.567 |
|
| CBL | $0.07 |
|
$0.09 | $0.03 |
|
||
| CGS | $2.60 |
|
$2.97 | $0.95 |
|
||
| CMP | $0.33 |
|
$0.42 | $0.24 |
|
||
| COH | $275.98 |
|
$323.00 | $246.14 | 39.7 |
$306.74 |
|
| CSX | $0.65 |
|
$0.88 | $0.31 |
|
||
| CU6 | $3.51 |
|
$6.44 | $1.43 |
$6.40 |
|
|
| CVB | $0.07 | 0.00% | $0.18 | $0.06 |
$0.15 |
|
|
| CYC | $0.68 |
|
$2.47 | $0.56 |
$1.50 |
|
|
| EBR | $1.04 |
|
$2.08 | $0.86 |
$2.645 |
|
|
| EMV | $1.82 |
|
$2.43 | $1.63 |
$3.15 |
|
|
| EYE | $0.13 |
|
$0.20 | $0.09 |
|
||
| FPH | $31.83 |
|
$35.75 | $29.08 | 49.0 |
|
|
| IME | $0.32 |
|
$0.45 | $0.22 |
$0.35 |
|
|
| IMR | $1.39 |
|
$1.86 | $0.89 |
$2.22 |
|
|
| IPD | $0.04 |
|
$0.06 | $0.03 |
$0.125 |
|
|
| LDX | $0.22 |
|
$0.28 | $0.02 |
|
||
| MX1 | $0.08 |
|
$0.12 | $0.04 |
$0.17 |
|
|
| NAN | $4.14 |
|
$5.18 | $2.88 | 61.0 |
$4.55 |
|
| ONE | $0.31 |
|
$0.38 | $0.17 |
$0.25 |
|
|
| PCK | $0.04 |
|
$0.11 | $0.02 |
|
||
| PEB | $0.15 | 0.00% | $0.19 | $0.05 |
|
||
| PGC | $0.30 |
|
$0.59 | $0.24 | 14.3 |
$0.495 |
|
| PME | $260.09 |
|
$336.00 | $161.64 | 174.0 |
$322.767 |
|
| RMD | $38.52 |
|
$45.25 | $32.04 | 22.2 |
$49.01 |
|
| SOM | $0.79 |
|
$0.95 | $0.34 | 49.4 |
$0.99 |
|
| TRJ | $0.67 |
|
$1.14 | $0.63 | 22.0 |
$1.25 |
|
2.60% 
Previous Stories
ResMed Shakes Off GLP-1 Scare
Feb 04 2025
The great obesity drug scare of 2023 is now behind ResMed as evidence in the December quarter suggests GLP-1s are actually a positive for the sleep apnoea industry
ResMed: Another Positive Quarterly Surprise?
Jan 30 2025
Tomorrow’s release is expected to reveal another strong quarter from ResMed
The Trend Remains Pro Medicus’ Friend
Jan 16 2025
The Chartist reports shares in Pro Medicus are having a breather, with the uptrend likely to continue
Diagnostic Imaging Radiates Opportunity
Dec 18 2024
Pending MRI deregulation is behind the now approved merger of Integral Diagnostics and Capitol Health, and analysts see significant opportunity
ResMed’s Bounce-Back Complete
Oct 29 2024
A stellar first quarter has underscored ResMed’s share price bounce-back from last year’s obesity drug panic, and perhaps put to bed the initial fear of GLP-1s
Dr Boreham’s Crucible: Pro Medicus
Sep 04 2024
The New Criterion’s Tim Boreham explains the ins and outs of one of the undisputed star performers on the ASX
Pro Medicus: Don’t Stop Me Now
Aug 20 2024
Michael Gable of Fairmont Equities reports it doesn’t look like Pro Medicus shares are in a mood to stop rising any time soon
Dr Boreham’s Crucible: Blinklab
May 20 2024
Recently ASX-listed Blinklab claims the world’s best mobile phone app for detecting autism, the New Criterion’s Tim Boreham reports
ResMed Silences The Doubters
Apr 29 2024
A forecast-beating jump in gross margins was the highlight in ResMed’s March quarter result
Dr Boreham’s Crucible: 4D Medical
Apr 23 2024
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
Latest News
| 1 |
ASX Winners And Losers Of Today – 25-11-256:35 PM - Daily Market Reports |
| 2 |
Picking A Lane: Car Platform Carma’s ASX Listing11:30 AM - Small Caps |
| 3 |
Weekly Update On LICs & LITs – 25-Nov-202511:10 AM - Weekly Reports |
| 4 |
4DMedical Poised For A Recovery10:45 AM - Technicals |
| 5 |
Nufarm’s Growing Optimism10:30 AM - Small Caps |